Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.42	19.47	9.66	179.29	274.74
Short-Term Investments	51.44	107.46	109.63	-	-
Cash & Short-Term Investments	66.86	126.93	119.3	179.29	274.74
Cash Growth	-47.33%	6.40%	-33.46%	-34.74%	3300.19%
Other Current Assets	5.25	5.51	5.31	7.32	3.94
Total Current Assets	72.11	132.44	124.6	186.61	278.67
Net Property, Plant & Equipment	19.42	22.14	24.81	24.77	1.24
Other Intangible Assets	-	2.6	24.31	-	-
Other Long-Term Assets	-	-	-	-	0.11
Total Assets	91.52	157.18	173.73	211.38	280.02
Accounts Payable	10.89	4.86	3.9	7.1	11.95
Accrued Expenses	8.55	11.37	12.97	24.54	6.59
Current Portion of Leases	1.69	1.45	1.23	-	0.17
Unearned Revenue	-	-	7.66	-	-
Total Current Liabilities	21.13	17.68	25.76	31.63	18.71
Long-Term Leases	16.98	18.75	20.1	18.92	-
Other Long-Term Liabilities	-	-	2.16	-	-
Total Long-Term Liabilities	16.98	18.75	22.26	18.92	-
Total Liabilities	38.11	36.43	48.02	50.56	18.71
Common Stock	0.06	0.06	0.05	0.03	0.03
Additional Paid-in Capital	496.47	484.08	411.82	373.23	353
Accumulated Other Comprehensive Income	0.05	0.17	0.06	-	-
Retained Earnings	-443.18	-363.56	-286.23	-212.44	-91.72
Total Common Shareholders' Equity	53.41	120.75	125.7	160.82	261.31
Shareholders' Equity	53.41	120.75	125.7	160.82	261.31
Total Liabilities & Equity	91.52	157.18	173.73	211.38	280.02
Total Debt	18.67	20.2	21.33	18.92	0.17
Net Cash (Debt)	48.18	106.73	97.97	160.37	274.57
Net Cash Growth	-54.85%	8.95%	-38.91%	-41.59%	3661.23%
Net Cash Per Share	0.78	1.83	2.46	4.86	32.33
Book Value	53.41	120.75	125.7	160.82	261.31
Book Value Per Share	0.86	2.07	3.15	4.87	30.77
Tangible Book Value	53.41	118.15	101.4	160.82	261.31
Tangible Book Value Per Share	0.86	2.02	2.54	4.87	30.77

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q